Clinical Trials Directory

Trials / Completed

CompletedNCT02101112

Bioavailability of Apixaban Crushed Tablet

Relative Bioavailability of Crushed Apixaban Tablets Administered With Water or Apple Sauce Compared With Intact Tablet in Healthy Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
69 (actual)
Sponsor
Bristol-Myers Squibb · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether the bioavailability of apixaban crushed tablets suspended in water or mixed with applesauce is similar to the bioavailability of apixaban whole tablets administered orally.

Detailed description

This study will investigate the bioavailability of apixaban administered as crushed tablets suspended in water and as crushed tablets mixed with applesauce compared with that of whole tablets. The study results may allow enhancement of the apixaban label to include alternative methods of apixaban administration, which may be of benefit to patients who have difficulty swallowing.

Conditions

Interventions

TypeNameDescription
DRUGApixaban

Timeline

Start date
2014-03-01
Primary completion
2014-05-01
Completion
2014-05-01
First posted
2014-04-01
Last updated
2016-03-03
Results posted
2016-03-03

Source: ClinicalTrials.gov record NCT02101112. Inclusion in this directory is not an endorsement.